| Skin Carcinoma altered in cohorts of …ALTERED_INderived200 of 274show all (up to 200) |
|---|
| ← altered in cohorts of | MUC12 24 / 25 cases (96 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 112 / 126 cases (89 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLEC 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN2 21 / 25 cases (84 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 103 / 126 cases (82 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP6 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH23 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5AC 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PPP1R3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRQ 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNRC18 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTCH1 221 / 293 cases (75 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 212 / 293 cases (72 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 28 / 39 cases (72 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 203 / 293 cases (69 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 27 / 39 cases (69 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 197 / 293 cases (67 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 82 / 126 cases (65 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 82 / 126 cases (65 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 80 / 126 cases (63 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 181 / 293 cases (62 %) · ssm · bcc_unige_2016 · largest of 5 cohorts | — | — | Skin Basal Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A5 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 77 / 126 cases (61 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 76 / 126 cases (60 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 75 / 126 cases (60 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 74 / 126 cases (59 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 74 / 126 cases (59 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 72 / 126 cases (57 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DGKB 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TAF1L 165 / 293 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 70 / 126 cases (56 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 70 / 126 cases (56 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 70 / 126 cases (56 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 70 / 126 cases (56 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 68 / 126 cases (54 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL22A1 68 / 126 cases (54 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FPGT-TNNI3K 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNXB 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF831 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 66 / 126 cases (52 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 66 / 126 cases (52 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 66 / 126 cases (52 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SI 65 / 126 cases (52 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2B 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRDM9 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7A 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRB3 149 / 293 cases (51 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 64 / 126 cases (51 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 63 / 126 cases (50 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 63 / 126 cases (50 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 144 / 293 cases (49 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLIT2 142 / 293 cases (48 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 61 / 126 cases (48 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 61 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 60 / 126 cases (48 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FMN2 60 / 126 cases (48 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 139 / 293 cases (47 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 59 / 126 cases (47 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 59 / 126 cases (47 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 59 / 126 cases (47 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 58 / 126 cases (46 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RELN 58 / 126 cases (46 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 57 / 126 cases (45 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 57 / 126 cases (45 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 57 / 126 cases (45 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 57 / 126 cases (45 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPTE 131 / 293 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 56 / 126 cases (44 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 56 / 126 cases (44 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 55 / 126 cases (44 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAGEC1 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 55 / 126 cases (44 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAPPA2 55 / 126 cases (44 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS2 54 / 126 cases (43 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NPAP1 54 / 126 cases (43 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN1A 54 / 126 cases (43 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PEG3 125 / 293 cases (43 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A4 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A6 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MROH2B 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH1 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH8 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL3 52 / 126 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 52 / 126 cases (41 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 52 / 126 cases (41 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KDR 120 / 293 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 119 / 293 cases (41 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRINP3 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL1A2 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH2 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGAM 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RIMS1 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TEX15 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A3 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN1 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SVEP1 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TMEM132D 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA3 116 / 293 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACAN 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFH 49 / 126 cases (39 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 49 / 126 cases (39 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 49 / 126 cases (39 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP5 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PXDNL 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN10A 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN9A 49 / 126 cases (39 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GPR158 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 48 / 126 cases (38 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO18B 48 / 126 cases (38 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRUNE2 48 / 126 cases (38 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN7A 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIOBP 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 110 / 293 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 47 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH17 47 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERICH3 47 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 47 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHA3 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCL1 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 109 / 293 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRB2 46 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM1 46 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VCAN 46 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCC 105 / 293 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA5 105 / 293 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRG4 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CHD7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL24A1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSTL5 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HRNR 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 45 / 126 cases (36 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ITPR1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRC7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KALRN 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL19A1 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FCGBP 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH2 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO16 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP13 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRXN1 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF536 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1A 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP47 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTN5 43 / 126 cases (34 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROBO2 99 / 293 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRM8 98 / 293 cases (33 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA6 97 / 293 cases (33 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA7 93 / 293 cases (32 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 93 / 293 cases (32 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALMS1 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VWF 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH3 89 / 293 cases (30 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SALL1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYCN 88 / 293 cases (30 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HGF 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRRAP 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCE1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP400 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRFN5 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH9 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC79 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH2 80 / 293 cases (27 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF213 79 / 293 cases (27 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BSN 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN2A 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMXL2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCB4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLX4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HECW1 76 / 293 cases (26 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC9 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |